Prolytix

About Prolytix

Prolytix performs GMP release testing for both commercial and clinical trial drug substances and drug products. We test bulk, final product, and in-process materials in our fully compliant, FDA-inspected facility. Combined with our other Chemistry, Manufacturing, and Control (CMC), Excipient and drug development services, you’re assured the highest quality from early-phase clinical devel...

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    United States
  • On CPHI since:
    2022
  • Certificates:
    4
  • Employees:
    25 - 49
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Laboratory Services
Contact info
  • (802) 878-1777
  • 57 River Road, #1021, 05452, Essex Junction, VT, United States
Show contact info Hide contact info

Prolytix Resources (1)

  • Improvements to PS80 Detection in Drug Product Formulations

    Whitepaper Improvements to PS80 Detection in Drug Product Formulations

    A Mixed-Mode High-Performance Liquid Chromatography Method for the Determination of Polysorbates Offers Notable Improvements Over a Conventional Reverse Phase HPLC Method. We are presenting an innovative enhancement to the conventional reverse phase (RP) High Performance Liquid Chromatography (HPLC) method utilized for the analysis of polysorbates, including Polysorbate 80 (PS80).The new and improved approach to polysorbate analysis involves mixed-mode HPLC. Mixed-mode HPLC offers several advantages over the RP method, including reduced run times, improved signal resolution, minimal sample preparation, and decreased reliance on consumables. These enhancements not only improve data analysis, but also lead to substantial cost savings compared to the RP method, while also reducing the potential errors associated with extensive sample handling.